pharm-analyt GmbH   Report issue

For profit Phase 1 Phase 2
Founded: Baden Austria (1986)

Organization Overview

First Clinical Trial
2010
NCT01194622
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pharm-Analyt Labor GmbH

Active Ingredients

Drugs in Phase 2 Trials (1)

nicardipine (cardene) (1 trial)

Drugs in Phase 1 Trials (2)

azelastine (astelin) (1 trial)

fluticasone (cutivate) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aneurysm (Phase 2)

Hemorrhage (Phase 2)

Rhinitis (Phase 1)

Rhinitis, Allergic (Phase 1)

Subarachnoid Hemorrhage (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3